Advertisement

Infectious Disease

Home Infectious Disease
B1/15 - Masks

College Campuses at Risk for Extreme Incidence of COVID-19

Colleges rapidly reduced the number of new infections, but many failed to control the spread beyond the campus

New Insights Into How COVID-19 Damages the Brain

Multifocal Microvascular Injury ID’d in Brain in COVID-19

No SARS-CoV-2 detected in postmortem samples, but brain may be susceptible to microvascular damage

HealthDay Reports: CDC Issues Call to Reopen America's Schools This Fall

Incidence of COVID-19 Increased in Children Since September

Trends for children tracked consistently with those of adults; incidence lower for children aged 0 to 10 years

One-Dose Covid-19 Vaccine From Johnson & Johnson Looks Promising

U.S. COVID-19 Vaccine Rollout Nears 1 Million Doses Per Day

News comes as Ohio State University researchers discover new variant of COVID-19 virus

HealthDay Reports: Black Americans Appear Most Vulnerable to Coronavirus

DKA Common in Blacks With T1DM and Confirmed COVID-19

Non-Hispanic Blacks with T1DM and COVID-19 have nearly fourfold increased odds of presenting with diabetic ketoacidosis

La vacuna de Pfizer contra la COVID parece promisoria

Ad26.COV2-S Vaccine Seems Safe, Immunogenic for SARS-CoV-2

Neutralizing antibodies detected in 90 percent or more of all participants on day 29 after the first vaccine dose

Negative COVID-19 Test to Be Required for People Flying to U.S.

Passengers without proof of a negative test will not be allowed to board flights to America

HealthDay Reports: Only Half of Americans Say They'd Get a Coronavirus Vaccine — Survey

COVID-19 Vaccine Recommended for All Americans Over 65

Health officials also recommended COVID-19 vaccines be given to all adults with preexisting conditions

B 1/13 -- New Insights Into How COVID-19 Damages the Brain

Link Between T. gondii Infection, Glioma Risk Examined

Significant increase in glioma risk seen for those with higher antibody titers to the sag-1 antigen

Routine COVID-19 Testing Improves Safety of Elective Surgery

Saliva, Nasopharyngeal Samples Equally Sensitive for SARS-CoV-2

Incremental cost of $8,093 per additional detection found with nasopharyngeal swab among individuals without previous SARS-CoV-2